Αρχική World News Hamlet Drug, Modeled After Protein In Breast Milk, Kills Tumor Cells While...

Hamlet Drug, Modeled After Protein In Breast Milk, Kills Tumor Cells While Leaving Healthy Ones Unharmed

For nearly 30 years, researchers have been testing an experimental drug called Hamlet on different cancers in both animals and humans.It was created as a replica of a protein found in human breast milk.A man-made version of alpha-lactalbumin — which is the most common protein found in human breast milk — Hamlet stands for Human Alpha-lactalbumin Made Lethal to Tumor cells. When the protein binds to oleic acid, a fatty acid that is thought to be anti-inflammatory, it can destroy cancer cells.It’s currently undergoing clinical trials in humans, and researchers have found that the drug can kill tumors cells while leaving healthy cells unscathed.At this point, it has been shown to kill 40 different types of cancer.OriginsPhoto: Adobe Stock/petunyia
Hamlet was created because of a happy accident. In 1995, at Lund University, Sweden, Professor Catharina Svanborg and her postgraduate student, Anders Håkansson, launched an experiment to figure out how breast milk was able to fight off germs and be considered antimicrobial.Human cancer cells are often used in scientific studies, whether or not the studies are focusing on cancer. This is because cancer cells can live on indefinitely, and since they are human cells, they provide a great opportunity for experimentation.The experiment didn’t go as planned, however, because the cancer cells began disappearing.After deeper analysis, Svanborg concluded that the breast milk was actually causing the cancer cells to undergo apoptosis — AKA, “commit suicide.”“Looking down the microscope at the dying tumor cells, we were quite excited, especially when the experiment was repeated and showed the same effect twice. We had used non-cancerous cells for a long time in similar experiments and they had not died,” Svanborg said.However, people in the medical community were skeptical and didn’t take the work seriously at first.
Additional TrialsPhoto: Adobe Stock/motortionSo Svanborg and her team have spent the last 30 years or so running experiment after experiment. Over this time, Hamlet has killed over 40 different types of cancer cells in multiple trials.In studies involving mice, Hamlet stunted the growth of brain and bladder tumors. In one study, baby mice were given Hamlet in their drinking water and didn’t develop colon cancer like they should have, indicating that Hamlet could be used in people with a genetic susceptibility to cancer.Then a trial on nine bladder cancer patients proved that Hamlet’s magic could work on humans as well. Eight of the nine patients passed tumors cells out of their body through their urine two hours after after they were given Hamlet. Their tumors shrank or changed character, and healthy surrounding tissue was not negatively affected.
Current TrialPhoto Credit: Adobe Stock/ninunThe current study is the largest trial of Hamlet to date, and involves 40 bladder cancer patients. It’s taking place in Prague, Czech Republic. Bladder cancer has a high recurrence rate and causes 200,000 deaths a year worldwide.Hamlet is given via a catheter into the bladder, with each patient getting six separate doses over a period of one month before undergoing surgery.Preliminary results should be available later in 2019, but the 40 patients will be monitored for two years so researchers can observe the long-term effects of the drug after treatment has ended.
Photo: Adobe Stock/Kateryna_KonHamlet is able to effectively kill cancer cells without harming healthy tissue — meaning little or no side effects, unlike chemotherapy and radiation.“We believe the treatment points to new ways of reaching a balance between therapeutic efficacy and side effects,” Svanborg said.The team is continuing to look at other cancers too, not just bladder cancer. Their ultimate goal to to use Hamlet as a preventative measure.
“If efficacy can be combined with a lack of toxicity, it is possible that this treatment can be used both as prevention and therapy. The vision would be to make it available worldwide, to patients who are susceptible to certain cancers, or who suffer from tumours that can be reached and treated with this substance,” Svanborg said.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Foodie Friday: It’s Berry Season!

July is National Berry Month! If berries aren’t part of your daily diet, now is the perfect time to start eating more of these...

No Link Between Viral Vector in Zynteglo and Acute Myeloid Leukaemia

On 23 July 2021, the European Medicines Agency (EMA) announced that its Committee for Medicinal Products for Human Use (CHMP) has endorsed findings of...

Expecting Mom Finds Pregnant Stray Cat And Gives Her A Home

A woman was 9 months pregnant when she found a pregnant stray cat. Unable to bear the thought of the fellow mom giving birth...

3 Questions Cancer Caregivers Can Ask Themselves to Help Prevent Burnout

Karen Warner Schueler is the president of her own executive coaching firm and author of The Sudden Caregiver: A Roadmap for Resilient Caregiving. For...

FDA Approval of Rylaze Will Address Drug Shortage for Childhood ALL

July 29, 2021, by NCI Staff FDA's approval of Rylaze is expected to help address a long-running shortage of the drug Erwinia asparaginase for kids...

EMA Recommends Granting a Marketing Authorisation for the Hybrid Medicine Imatinib

On 22 July 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...